Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.
File(s)leaderfinalpolyvascular.docx (367.7 KB)
Accepted version
Author(s)
Type
Journal Article
Date Issued
2018-05-15
Date Acceptance
2018-05-01
Citation
Circulation, 2018, 137 (20), pp.2179-2183
ISSN
0009-7322
Publisher
American Heart Association
Start Page
2179
End Page
2183
Journal / Book Title
Circulation
Volume
137
Issue
20
Copyright Statement
© 2018 American Heart Association, Inc.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/29760228
PII: CIRCULATIONAHA.118.033898
Subjects
atherosclerosis
diabetes mellitus, type 2
glucagon-like peptide 1
liraglutide
myocardial infarction
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2018-05-15